Showing results (221-230 of 256) with videos related to

Sort By:
Pageof 26
Lancet (London, England)|February 28, 1987
Evaluation of a clinical case-definition of acquired immunodeficiency syndrome in AfricaR Colebunders, J M Mann, H Francis, et al.
The Journal of Infectious Diseases|February 13, 1999
Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the CongoK Kibadi, K Mupapa, K Kuvula, et al.
The Journal of Infection|September 1, 1990
Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, ZaireR Colebunders, Y Bahwe, W Nekwei, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 15, 2010
Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in UgandaD Nakanjako, H Mayanja-Kizza, J Ouma, et al.
AIDS (London, England)|June 17, 1999
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study groupA Mocroft, O Kirk, S E Barton, et al.
The Journal of Infectious Diseases|February 1, 1988
Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infectionR Colebunders, J M Mann, H Francis, et al.
HIV Medicine|December 12, 2001
Therapeutic vaccination (p24-VLP) of patients with advanced HIV-1 infection in the pre-HAART era does not alter CD4 cell declineD Smith, I Gow, R Colebunders, et al.
Epidemiology and Infection|February 1, 2003
Regional and temporal changes in AIDS in Europe before HAARTA Blaxhult, Z Fox, R Colebunders, et al.
HIV Medicine|December 12, 2001
Does European or non-European origin influence health care and prognosis for HIV patients in Europe? The EuroSIDA Study GroupA Blaxhult, A Mocroft, A Phillips, et al.
Journal of Clinical Immunology|November 1, 1991
Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infectionG Vanham, L Kestens, G Penne, et al.
Pageof 26